Neonatal Marfan syndrome: a successful early multidisciplinary approach

BMJ Case Rep. 2014 Jun 13:2014:bcr2013202438. doi: 10.1136/bcr-2013-202438.

Abstract

Marfan syndrome (MFS) is a genetic disorder of the connective tissue which rarely manifests in the neonatal period and has an ominous prognosis. A case of a first female offspring of healthy parents is described here. The pregnancy was uneventful and the mother had a term caesarean delivery. At birth, some dysmorphic signs became apparent, such as loose redundant skin, dolichocephaly, frontal bossing, deeply sunken eyes, micrognathia, contractures of the elbows, arachnodactyly and hip dysplasia. The echocardiogram showed a mitral and tricuspid valve regurgitation and a long aortic arch. The diagnosis of neonatal MFS came forward and genetic studies revealed a de novo mutation in the fibrillin 1 (FBN1) gene. At 6 months, due to a progressive worsening of the cardiac pathology, she was submitted to mitral valvuloplasty. She is now 2 years and 10 months old, which is a remarkable feat for a child suffering from this condition.

Publication types

  • Case Reports

MeSH terms

  • Aorta, Thoracic / abnormalities*
  • Female
  • Fibrillin-1
  • Fibrillins
  • Humans
  • Infant, Newborn
  • Marfan Syndrome / diagnosis*
  • Marfan Syndrome / genetics
  • Marfan Syndrome / therapy
  • Microfilament Proteins / genetics
  • Mitral Valve Insufficiency / diagnostic imaging
  • Mitral Valve Insufficiency / genetics
  • Mitral Valve Insufficiency / therapy
  • Mutation / genetics
  • Patient Care Team
  • Tricuspid Valve Insufficiency / diagnostic imaging
  • Tricuspid Valve Insufficiency / genetics
  • Tricuspid Valve Insufficiency / therapy
  • Ultrasonography

Substances

  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins
  • Microfilament Proteins